Drug Study Archives - BCDiabetes

Petition: Lobby BC Pharmacare to cover lifesaving SGLT2 inhibitor diabetes treatment

Dr. Tom Elliott — Mon, 14 Nov 2016 17:46:06 +0000

BCDiabetes Medical Director, Dr. Tom Elliott, has launched a petition to lobby BC Pharmacare to cover SGLT2 inhibitors. As many as 50,000 British Columbians would likely benefit from SGLT2 inhibitors, but many do not have funds or coverage. This class of drug has been shown to reduce mortality for those at high risk of heart […]

The post Petition: Lobby BC Pharmacare to cover lifesaving SGLT2 inhibitor diabetes treatment appeared first on BCDiabetes.

New Study Questions Effectiveness of Type 2 Diabetes Treatment

Dr. Tom Elliott — Tue, 20 Sep 2016 21:44:55 +0000

New study questions Type 2 diabetes treatment “No evidence glucose-lowering drugs help ward off long-term complications, researchers say.” This is a massive statement so we sought our medical director, Dr. Tom Elliott, for insight. The CBC recently reported on a publication by Dr. Victor Montori, of the Mayo Clinic in Circulation: Cardiovascular Quality and Outcomes arguing a […]

The post New Study Questions Effectiveness of Type 2 Diabetes Treatment appeared first on BCDiabetes.

Important Type 2 Diabetes Results Reported

Dr. Tom Elliott — Wed, 15 Jun 2016 17:44:36 +0000

Today the results of 2 important studies in Type 2 diabetes presented at the annual American Diabetes Association meeting in New Orleans this week were published in the prestigious New England Journal of Medicine. The LEADER study examined the outcomes of 9,340 patients with Type 2 diabetes followed for four years. All took standard diabetes […]

The post Important Type 2 Diabetes Results Reported appeared first on BCDiabetes.

New Study To Test Whether GLP-1 Agents Help You or Hurt You Before Taking The Drug

Dr. Tom Elliott — Tue, 22 Sep 2015 22:37:43 +0000

We are very excited about this made-in-BC research to help us find out if a drug will be beneficial for those taking it or whether it might make them ill before ever taking the drug. From Dr. Tom Elliott: “A new class of medication for diabetes known as GLP-1 agents have been on the Canadian market […]

The post New Study To Test Whether GLP-1 Agents Help You or Hurt You Before Taking The Drug appeared first on BCDiabetes.

BC Diabetes Joins PERL Study

Dr. Tom Elliott — Tue, 22 Sep 2015 22:25:19 +0000

We are very happy to announce that we have been added to a prestigious roster or institutions and organizations from across North America. This study is examining how a drug might help prevent kidney disease in people with Type 1 diabetes. To hear from the principal investigators, please click here to watch a brief video […]

The post BC Diabetes Joins PERL Study appeared first on BCDiabetes.

U.S. FDA warns on SGLT2 inhibitors, a class of type 2 diabetes drugs

Dr. Tom Elliott — Wed, 20 May 2015 13:52:22 +0000

This past Friday the US Federal Drug Administration released a warning that some newer type 2 diabetes drugs, known as SGLT2 inhibitors, may cause ketoacidosis, or dangerously high levels of blood acids that could require hospitalization. The warning comes from the US, but what does this mean for Canada. Our Medical Director, Dr. Tom Elliott, lets us know. […]

The post U.S. FDA warns on SGLT2 inhibitors, a class of type 2 diabetes drugs appeared first on BCDiabetes.

Our new Type 1 diabetes study puts us in the spotlight

Dr. Tom Elliott — Thu, 23 Apr 2015 14:06:54 +0000

We have had a very busy week as news of our latest Type 1 diabetes study, sponsored by UBC and the JDRF Canadian Clinical Trials Network, is making the news. In the past 48 hours, our medical director, Dr. Tom Elliott, along with various members of our team and study participants, have appeared on the […]

The post Our new Type 1 diabetes study puts us in the spotlight appeared first on BCDiabetes.